Author:
Zawati Ma'n H.,Chalmers Don,Dallari Sueli G.,de Neiva Borba Marina,Pinkesz Miriam,Joly Yann,Chen Haidan,Hartlev Mette,Leitsalu Liis,Soini Sirpa,Rial-Sebbag Emmanuelle,Hoppe Nils,Garani-Papadatos Tina,Vidalis Panagiotis,Srinivas Krishna Ravi,Siegal Gil,Negri Stefania,Hatanaka Ryoko,Al-Hussaini Maysa,Al-Tabba' Amal,Motta-Murgía Lourdes,Moran Laura Estela Torres,Hendriks Aart,Nnamuchi Obiajulu,Isasi Rosario,Krekora-Zajac Dorota,Sadoun Eman,Ho Calvin,Andanda Pamela,Lee Won Bok,Nicolás Pilar,Mattsson Titti,Talanova Vladislava,Dosch Alexandre,Sprumont Dominique,Fan Chien-Te,Hung Tzu-Hsun,Nnamuchi Obiajulu,Kaye Jane,Phillips Andelka,Gowans Heather,Shah Nisha,Hazel James W.
Publisher
Cambridge University Press (CUP)
Subject
Health Policy,General Medicine,Issues, ethics and legal aspects
Reference642 articles.
1. 15. Id., § 17.
2. 22. NBC-NBBLSC, “Test genetici di suscettibilità e medicina personalizzata,” (Genetic Susceptibility Testing and Personalised Medicine), July 14, 2010, available at (last visited October 23, 2019).
3. 2. National Pathology Accreditation Advisory Council (NPAAC), Department of Health, Australian Government, The Provision of Direct to Consumer Genetic Tests: Guiding Principles for Providers, 2014, available at (last visited October 10, 2019).
4. 6. “Adequacy Decisions: How the EU Determines if a Non-EU Country has an Adequate Level of Data Protection,” Eur. Comm, available at (last visited October 22, 2019).
5. 15. FADP, supra note 11.